• GU Ventures portfolio company PExA expanded its global footprint in 2026, citing multiple international commercial wins.
• Signed a contract worth about SEK 7.5 million in June with one of the world’s 10 largest pharmaceutical companies.
• Secured a system upgrade order from a US government customer; also reported orders from the Norwegian state.
• PExA technology will feature in three accepted scientific presentations at the ERS International Congress in Barcelona on Sept. 5-9.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GU Ventures AB published the original content used to generate this news brief on September 08, 2026, and is solely responsible for the information contained therein.